DCF — ST. JOSEPHS REG MED CENTER PLYMOUTH
Enterprise Value: $-27.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-27.3M
Enterprise Value
$-10.1M
PV of Cash Flows
$-17.2M
PV of Terminal Value
$-27.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $60.0M | $-0.9M | -2.0% | $-3.5M | $-3.1M |
| Year 2 | $61.8M | $-0.3M | -1.0% | $-2.9M | $-2.4M |
| Year 3 | $63.7M | $0.3M | 0.0% | $-2.4M | $-1.8M |
| Year 4 | $65.6M | $0.6M | 1.0% | $-2.1M | $-1.5M |
| Year 5 | $67.5M | $0.8M | 1.0% | $-2.0M | $-1.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-27.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$58.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.02018670422410274
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5